The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Emerging Therapies in ER+ Metastatic Breast Cancer

Sarat Chandarlapaty, MD, PhD
Published Online: 4:28 PM, Tue July 26, 2016

Sarat Chandarlapaty, MD, PhD, medical oncologist, Memorial Sloan Kettering, discusses some of the emerging therapies for patients with ER-positive metastatic breast cancer.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.